Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news

Show

From To
Gilead Continues To Block Ireland From Sourcing Generic Truvada

Gilead Sciences, the company that supplies Ireland with the drug Truvada, will have a full court hearing in mid-October to determine whether the Irish Health and Safety Executive (HSE) can source a generic analogue of the drug from the pharmaceutical giant’s competitors. In July, GCN reported that Gilead was taking legal action to stop the HSE from securing generic drug from Actavis and Mylan, the company’s competitors, for the purposes of HIV prevention as PrEP.

Published
16 October 2017
From
Gay Community News
STI warning as clinics close in London and self-testing is delayed

People are being denied care at overburdened sexual health clinics after a wave of closures and huge delays to a controversial new self-testing scheme for diseases such as herpes and syphilis, health experts are warning.

Published
16 October 2017
From
The Guardian
New report details health crisis in Venezuela

Venezuela is in the middle of an unprecedented, statemade, complex humanitarian emergency with severe and widespread social consequences. Its AIDS program, once lauded as a model, has collapsed, with chronic drug shortages and the lack of condoms or diagnostic tests putting thousands at risk of preventable diseases and death.

Published
16 October 2017
From
ICASO
Doctors Are Worried That NHS Charges Will Stop Vulnerable Patients Getting The Treatment They Need

Overseas patients will soon be legally required to pay upfront for some NHS treatments, which many professionals say will get in the way of treating them safely.

Published
13 October 2017
From
BuzzFeed
Moscow Buyers Club: Russia's AIDS Patients Work Together To Overcome Medication Shortages

Problems with the distribution of HIV/AIDS medications have become endemic in Russia, forcing patients to increasingly rely on one another to get the treatments they need. The situation in Russia in 2017 has come to resemble the plot of the Hollywood movie Dallas Buyers Club, which was set in the United States in the 1980s.

Published
09 October 2017
From
Radio Free Europe
Hepatitis C Drug’s Lower Cost Paves Way For Medicaid, Prisons To Expand Treatment

Valerie Green is still waiting to be cured. The Delaware resident was diagnosed with hepatitis C more than two years ago, but she doesn’t qualify yet for the Medicaid program’s criteria for treatment with a new class of highly effective but pricey drugs. The recent approval of a less expensive drug that generally cures hepatitis C in just eight weeks may make it easier for more insurers and correctional facilities to expand treatment.

Published
05 October 2017
From
Kaiser Health News
The Medicines Patent Pool and Gilead Sciences Sign Licence for Bictegravir

The Medicines Patent Pool (MPP) today announced a licence with Gilead Sciences for bictegravir (BIC), now under review in the United States and the European Union as part of a once-daily, single-tablet HIV regimen. The licence allows manufacturers to develop and sell generic medicines containing BIC, if approved in the United States, in 116 low- and middle-income countries where more than 30 million people live with HIV.

Published
04 October 2017
From
Medicines Patent Pool
Protesters stage London demo against plans for patient ID checks

Critics fear checks will destroy relationship NHS staff have with patients and create climate of fear that stops people accessing care

Published
02 October 2017
From
The Guardian
Nigeria: Govt to Provide ARV for 50,000 Additional People Living With HIV Yearly

The Nigerian government has made new commitments to use domestic funds to provide antiretroviral drugs to an additional 50,000 people living with Human Immuno Virus (HIV) each year in the country.

Published
29 September 2017
From
AllAfrica
Achieving National HIV/AIDS Strategy targets would save lives, be cost effective

An analysis led by a team of Massachusetts General Hospital investigators shows that achieving the treatment targets of the National HIV/AIDS Strategy by 2020 not only would prevent hundreds of thousands of new infections and deaths but also would demonstrate excellent value.

Published
28 September 2017
From
Eurekalert Inf Dis
← First12345...128Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.